Connect with us

Business

Market Drops on Failed Coronavirus Treatment Trial, 4.4 Million More Job Losses

Avatar

Published

on

Market Drops on Failed Coronavirus Treatment Trial, 4.4 Million More Job Losses

The stock market was off to a good start yesterday, with the Dow Jones Industrial Average trading as much as 400 points higher before news broke that Gilead Sciences malaria drug Remdesivir didn’t help speed the recovery of coronavirus patients during a clinical trial in China.

The Dow closed the day up 39 points, with the S&P 500 closing down just over one point and the Nasdaq losing less than a point.

Many had hoped Remdesivir would offer treatment against the coronavirus. This includes President Trump, who just last month mentioned that the drug “seems to have a very good result.”

Gilead (Nasdaq: GILD) shares dropped 4.34% after the Financial Times reported the failed clinical trial, citing a report on the World Health Organization’s website.

A spokesperson for the WHO confirmed that the report was shared early and taken down.

Not Giving Up Yet

However, Jim Cramer, host of Mad Money, said in a series of tweets that we should wait until the results of a U.S. clinical trial are in before we write off the drug’s potential.

“I say wait until the American studies come out. University of Chicago study is a lot more rigorous. I would stick with that. You don’t have to believe it. But this is the third time the Chinese have said the drug doesn’t work.”

He added in a separate tweet “This will be the last time I mention remdesivir again. Do you trust the University of Chicago Med School doing a real study, or the Chinese doing a fake one? All your call.”

Also dragging down the markets were the latest initial jobless claims report and new home sales for March.

The initial jobless claims report showed that another 4.4 million Americans filed for benefits last week.

That brings the five-week total to more than 26 million Americans filing for unemployment benefits. We’ve now seen job losses officially exceed the 22.4 million jobs created in the 11 years since the country started coming out of the Great Recession.

New home sales in March fell 15.4% to a seasonally-adjusted level of 627,000 units. That’s the lowest level of new home sales since July 2013. Additionally, the median sales price slipped from $330,100 down to $321,400.

A Ray of Light

Surprisingly, the lone bright spot yesterday in the markets was oil, which lately has been anything but a bright spot.
The price of West Texas Intermediate crude jumped 20% yesterday to close at $16.50 per barrel. This followed a similar gain on Wednesday. Since Tuesday’s low of $11.57 per barrel, oil has gained 42%.

Prices got a boost from a tweet by President Trump which stated: “I have instructed the United States Navy to shoot down and destroy any and all Iranian gunboats if they harass our ships at sea.”

The tweet is referencing a report from the Pentagon claiming that ships from Iran’s Islamic Revolutionary Guard Corps Navy took “dangerous and provocative” actions near U.S. Navy and Coast Guard ships in the Persian Gulf.

Oil is still down nearly 70% for the year, and inventories are expected to continue building for the next 4-6 weeks, meaning this rally could be short-lived.

Up Next: 

Business

SPACs Are Red Hot, Here’s One You Probably Want To Avoid

Avatar

Published

on

SPACs Are Red Hot, Here’s One You Probably Want To Avoid

Last week we discussed SPACs, or special purpose acquisition companies, the red-hot investment trend that has taken off like a rocket this year.

According to Renaissance Capital, in just the last 9 days, 14 SPACs have filed to raise a sum of $5.5 billion. Year-to-date, there have been 57 SPACs created and combined they have raised $21.3 billion in the IPO market. This includes Bill Ackman’s $4 billion Pershing Square Tontine Holdings Ltd.

For comparison, last year a total of 59 blank check companies raised $12.1 billion. This was considered a record at the time. So with almost four full months left this year, we’ve nearly exceeded last year’s total.

“We’re about to break last year’s full-year SPAC IPO count of 59, the highest number in a year ever. And based on recent filings, activity is only going to increase heading into the fall,” said Matthew Kennedy, a senior strategist at Renaissance Capital.

We pointed out a few promising SPACs in last week’s article. However, a recent filing is one that you definitely want to avoid. It also highlights the importance of doing due diligence before you invest.

Investing in SPACs Wisely

A company called Burgundy Technology Acquisition Corp. filed a preliminary prospectus last week. It said it is looking to raise $400 million. Burgundy will be led by former Hewlett-Packard and SAP AG Chief Executive Leo Apotheker. Apotheker will also be co-CEO of Burgundy along with former SAP colleague James Mackey.

Unless you are a student of Hewlett-Packard history, you likely don’t remember the tenure of Apotheker, which only lasted about a year. That’s because while he was CEO, Apotheker oversaw what many consider to be one of the worst, if not the absolute worst, acquisitions in corporate history.

Hewlett Packard acquired a data analytics software company called Autonomy for $11 billion. Before the deal even closed, Chief Financial Officer Cathie Lesjak expressed concerns about the hefty price, yet Apotheker pushed on to close the deal. There were even concerns about Autonomy’s aggressive accounting tactics.

The end result is that Apotheker was fired a little more than a month after the deal was closed and Hewlett-Packard wrote off $8.8 billion of the purchase price less than a year later. The company admitted it had substantially overvalued Autonomy, and nearly a decade later, lawsuits are still pending over the acquisition.

Most appalling, in his testimony as part of the numerous lawsuits, Apotheker admitted that he never bothered to read Autonomy’s most recent financial results before signing the deal, which lawyers pointed out would have taken him about 30 minutes.

“I was running a $125 billion company, sir, and minutes are pretty precious,” Apotheker testified.

Now he’s back, hoping to have a $400 million blank check to go looking for a company to acquire.

This time around, will he take the time to read financial statements?

Up Next:

Continue Reading

Business

It’s Not ‘Unreasonable’ To See Gold Prices Soar To $4000 During Bull Market

Avatar

Published

on

It’s Not ‘Unreasonable’ To See Gold Soar To $4000 During Bull Market

Despite gaining 35% this year, gold prices have plenty of room to run, says Michael Cuggino, the CEO of the Permanent Portfolio Family of Funds.

Cuggino says that since gold formed a triple bottom from the end of 2015 through November of 2018, it has consistently climbed higher and has really soared this year.

“Ever since then, it has been a gradual move up, then some down. It moves sometimes in big chunks, gives some back, sits around and does nothing, reacts to stimulus, inflation, the value of dollar and euro … but it has had an aggressive move this year,” Cuggino said.

Possible Setbacks Along the Way?

With gold climbing so quickly in a relatively short period of time, Cuggino warns there could be sharp pullbacks along the way. But he says the overall trend is for higher gold prices.

Cuggino says the recipe of continued money printing by the government, the dollar steadily declining and growing inflationary fears mean it would “not be an unreasonable move” to see gold prices soaring to $4,000 an ounce.

He points to a metric that compares gold prices to the closing levels for the S&P 500 index. Gold is currently trading at 0.6 times the level of the S&P 500 and it hasn’t climbed above 0.7 since 2014. But when you go back to August 2011, gold traded as high as 1.7 times the S&P 500, so there’s plenty of upside for gold prices.

Gold Still Has a Long Way to Go

Just adjusting for inflation, gold would need to climb above $2,800 per ounce to equal 1980 levels, which means this gold rally has a long way to go.

Mike Shedlock, the Mish Talk blogger and investment adviser at SitkaPacific Capital Management, thinks the fuel that could push gold to $2,800 per ounce could come from all the hedge funds that are currently on the sidelines and missed the early innings of the gold rally.

“There is ample room for Fear of Missing Out to kick in as the managed money and big spec hedge funds sat out much of the recent rally,” he writes. “And with 105,025 short contracts there is plenty of fuel for a short squeeze too.”

E.B. Tucker, director of Metalla Royalty and Streaming, believes that the current rally will continue, and he thinks gold prices could hit $2,500 by the end of the year.

“Normally I would say [the bull run is overheated] but what I’m seeing in the daily action is that gold is rising in a very measured way and is not meeting much resistance, so when that’s happening you just step out of the way and let it go, that’s what you do,” Tucker said.

Like Cuggino, Tucker says there could be pullbacks in price along the way, but he says we’re in a secular bull market like we may never see again.

“This is a secular bull market. This is a bull market in gold that you’re probably never going to see in the course of your life again.”

Up Next:

Continue Reading

Business

Nasdaq Sets A New Record, Dow Forms A ‘Golden Cross’

Avatar

Published

on

Nasdaq Sets A New Record, Dow Forms A ‘Golden Cross’

Since bottoming in late March, the stock market continues to set records in what seems like an almost invincible climb higher.

Nevermind that Jim Cramer said the rally is being driven by the “power of enthusiastic buyers who do not know what they’re doing” and that he can’t fathom “how stupidly bullish this market can be,” the fact is that stocks are climbing higher.

The latest evidence for a runaway stock market is that the Nasdaq Composite Index just gained 1,000 points. It happened in the shortest amount of time in the last 20 years.

1000-Point Climb

It took 114 days for the index to climb from the 9,000 level to the 10,000 level. That milestone was hit on June 10 of this year.

In just 40 days since, the Nasdaq has tacked on another 1,000 points, climbing above the 11,000 level.

That is the fastest 1000-point gain for the index since it took a blistering 38 days in 1999. Back then, it climbed from the 3,000 level to the 4,000 level.

You might recall that period, it was during the dot-com bubble. We know how that ended.

Today’s 1000-point climb is only a 10% overall gain (from 10,000 to 11,000) compared to the 33% overall gain during the ‘99 surge (from 3,000 to 4,000). However, it’s still a blistering pace that investors pay attention to.

“Although 11,000 by itself doesn’t mean much, these big round numbers are a nice reminder of just how strong this rally has been since the March lows,” said Ryan Detrick, the chief investment strategist at LPL Financial.

A ‘Golden Cross’

Not wanting to miss the fun, the Dow Jones Industrial Average just flashed its own bullish signal to investors.

The index just formed a “golden cross,” where the shorter-term 50-day moving average crosses above the long-term 200-day moving average.

Investors consider this to be a bullish signal for the index, as it shows the short term momentum is strong.

Conversely, when the 50-day moving average crosses below the 200-day it’s called a “death cross” and is a bearish indicator. The last “death cross” was on March 20. On that day, the stock market was pummeled by the economic shutdown caused by the coronavirus pandemic.

With the rally being led by technology stocks, the Nasdaq – which is more than 50% tech stocks – has gained more than 60% since the March lows. The S&P 500 is made up of about 25% tech stocks and has gained nearly 50% since March, and only 20% of the Dow is tech stocks so it’s lagged behind, gaining only 47% since March.

How reliable is the “golden cross” for stocks to move higher? According to Dow Jones Market Data, the last time a “golden cross” failed was in January 2016. That was also the last time the market slipped lower.

Up Next:

Continue Reading
Advertisement

Facebook

Trending

Copyright © 2019 The Capitalist. his copyrighted material may not be republished without express permission. The information presented here is for general educational purposes only. MATERIAL CONNECTION DISCLOSURE: You should assume that this website has an affiliate relationship and/or another material connection to the persons or businesses mentioned in or linked to from this page and may receive commissions from purchases you make on subsequent web sites. You should not rely solely on information contained in this email to evaluate the product or service being endorsed. Always exercise due diligence before purchasing any product or service. This website contains advertisements.

[email]
[email]